scholarly article | Q13442814 |
P2093 | author name string | S Jelic | |
N Pavlidis | |||
ESMO Guidelines Task Force | |||
R Stupp | |||
P304 | page(s) | i64-5 | |
P577 | publication date | 2005-01-01 | |
P1433 | published in | Annals of Oncology | Q326122 |
P1476 | title | ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of malignant glioma | |
P478 | volume | 16 Suppl 1 |
Q51708520 | 3D conformal radiotherapy and cisplatin for recurrent malignant glioma. |
Q42113451 | A Phase II randomized study of galunisertib monotherapy or galunisertib plus lomustine compared with lomustine monotherapy in patients with recurrent glioblastoma |
Q61796646 | Brown Seaweed 's Cytotoxic Activity against Brain Cancer Cell Lines |
Q90334393 | Curcumin-induced cell death depends on the level of autophagic flux in A172 and U87MG human glioblastoma cells |
Q38593139 | Endocannabinoids and Cancer. |
Q42425989 | FasL gene knock-down therapy enhances the antiglioma immune response |
Q27333552 | Glioma initiating cells form a differentiation niche via the induction of extracellular matrices and integrin αV |
Q37109249 | Inhibition of glioma growth by minocycline is mediated through endoplasmic reticulum stress-induced apoptosis and autophagic cell death |
Q28082580 | Ion transporters in brain tumors |
Q44517700 | Management and survival rates in patients with glioma in China (2004-2010): a retrospective study from a single-institution |
Q47967307 | Myo-inositol concentration in MR spectroscopy for differentiating high grade glioma from primary central nervous system lymphoma. |
Q37407066 | Phase II study of bevacizumab in combination with sorafenib in recurrent glioblastoma (N0776): a north central cancer treatment group trial |
Q37700702 | Potential regulation of glioma through the induction of apoptosis signaling via Egl-9 family hypoxia-inducible factor 3 |
Q34584754 | Prognostic factors for survival in 676 consecutive patients with newly diagnosed primary glioblastoma |
Q55463292 | Prognostic value of plasma d-dimer levels in patients with glioblastoma multiforme - Results from a pilot study. |
Q35681474 | S100B-p53 disengagement by pentamidine promotes apoptosis and inhibits cellular migration via aquaporin-4 and metalloproteinase-2 inhibition in C6 glioma cells |
Q48372089 | Signaling switch of the urotensin II vasosactive peptide GPCR: prototypic chemotaxic mechanism in glioma. |
Q28390962 | Small solutions for big problems: the application of nanoparticles to brain tumor diagnosis and therapy |
Q36231572 | The Prognosis of Anti-Angiogenesis Treatments Combined with Standard Therapy for Newly Diagnosed Glioblastoma: A Meta-Analysis of Randomized Controlled Trials |
Q64061395 | The Volume-Regulated Anion Channel in Glioblastoma |
Q55501535 | The prognosis for patients with newly diagnosed glioblastoma receiving bevacizumab combination therapy: a meta-analysis. |
Q54946129 | UniPR1331, a small molecule targeting Eph/ephrin interaction, prolongs survival in glioblastoma and potentiates the effect of antiangiogenic therapy in mice. |
Q30572906 | WNK1-OSR1 kinase-mediated phospho-activation of Na+-K+-2Cl- cotransporter facilitates glioma migration |
Search more.